Small interfering RNA targeting N‑cadherin regulates cell proliferation and migration in enzalutamide‑resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Small interfering RNA targeting N‑cadherin regulates cell proliferation and migration in enzalutamide‑resistant prostate cancer

Published:2022-01-21 Issue:3 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Lu Cheng-Hsin¹,Wu Chun-Hsien²,Hsieh Pei-Fang²,Wu Chen-Yu²,Kuo Wade²,Ou Chien-Hui³,Lin Victor²

Affiliation:

1. Division of Urology, Penghu Hospital, Penghu 880001, Taiwan, R.O.C.

2. Division of Urology, Department of Surgery, E‑Da Hospital, Kaohsiung 824005, Taiwan, R.O.C.

3. Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704302, Taiwan, R.O.C.

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference50 articles.

1. High-risk prostate cancer in the United States, 1990-2007;Cooperberg;World J Urol,2008

2. Contemporary role of androgen deprivation therapy for prostate cancer;Pagliarulo;Eur Urol,2012

3. Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells;Liu;Int J Oncol,2012

4. Mechanisms of resistance in castration-resistant prostate cancer (CRPC);Chandrasekar;Transl Androl Urol,2015

5. Treatment of advanced prostate cancer;Teo;Annu Rev Med,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytochrome P450 genes expression in human prostate cancer;Molecular Genetics and Metabolism Reports;2024-03

2. Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model;Cancers;2024-02-19

3. Epigenetic regulation of epithelial–mesenchymal transition during cancer development;Epigenetic Regulation of Cancer - Part A;2023

4. An Overview of siRNA Delivery Strategies for Urological Cancers;Pharmaceutics;2022-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3